Filter By Industry
Filter By Tag

Newsroom

NMS Group S.p.A. Press releases

1 - 3 of 3 Press Releases

Sari Announces Closing Of Nms Acquisition
Mar 29, 2018
SARI, a Chinese market-leader biotech investment company, is pleased to announce that it has closed the previously announced agreement to acquire the 90% interests in NMS Group S.p.A., effective from today.

SARI today announced it has entered into an agreement to acquire the 90% interests in NMS Group
Dec 27, 2017
SARI is a Chinese market-leader biotech investment company. The total value of the deal, a mix of equity injection and debt restructuring, is around 300 mln Euro

Nerviano Medical Sciences presents data regarding a potent new cytotoxic molecule for ADC generation
Oct 19, 2016
NMS-P945 is a potent, innovative and proprietary cytotoxic molecule in the NMS pipeline, highly suited to conjugation with targeted antibodies


NMS Group S.p.A. RSS Feed